Nippon Kayaku Co., Ltd.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Maruho Obtains Rights To GI-301 No

Japanese bioventure Solasia Pharma K.K. 's Darvias (darinaparsin; SP-02) has received its first approval in Japan for the treatment of relapsed/refractory peripheral T-cell lymphoma (PTCL), marking t

Germany’s Stada Arzneimittel has looked to the fast-moving consumer goods sector to recruit a head for its domestic operations. Former Reckitt Benckiser, Unilever and Procter & Gamble employee Eelco

Amid heating up competition for its best-selling immuno-oncology agent, Bristol-Myers Squibb Co. has made a key leadership change in China. The US firm's country general manger Shirley Zhao is lea